Cytotoxic effect of lomefloxacin in culture of human epidermal melanocytes

Pharmacological Reports

Volumn 65, Issue 3, 2013, Pages 689-699

  Beberok, Artur ^a   Otreba, Michał ^a   Wrześniok, Dorota ^a   Buszman, Ewa ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Drug melanin complexes; Lomefloxacin; Melanin; Melanization; Melanocytes

Indexed keywords

LOMEFLOXACIN; MELANIN; MONOPHENOL MONOOXYGENASE;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL VIABILITY; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MELANOCYTE; MELANOGENESIS;

ANTI-BACTERIAL AGENTS; BINDING SITES; CELL SURVIVAL; CELLS, CULTURED; FLUOROQUINOLONES; HUMANS; MELANINS; MELANOCYTES; SKIN;

EID: 84884488196     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71047-8     Document Type: Article

References (46)

1. Beberok A, Buszman E, Wrzeoeniok D: Interaction of norfloxacin and sparfloxacin with melanin in relation to phototoxic reactions. Ann Univ Mariae Curie Skłodowska Sectio DDD Pharm, 2009, 4, 87-92.
2. Beberok A, Buszman E, Wrzeoeniok D, Otre{ogonek}ba M, Trzcionka J: Interaction between ciprofloxacin and melanin: The effect on proliferation and melanization in melanocytes. Eur J Pharmacol, 2011, 669, 32-37.
3. Beberok A, Buszman E, Zdybel M, Pilawa B, Wrzeoeniok D: EPR examination of free radical properties of DOPA-melanin complexes with ciprofloxacin, lomefloxacin, norfloxacin and sparfloxacin. Chem Phys Lett, 2010, 497, 115-122.
4. Bridelli MG, Ciati A, Crippa PR: Binding of chemicals to melanins re-examined: Adsorption of some drugs to the surface of melanin particles. Biophys Chem, 2006, 20, 137-145. (Pubitemid 43105450)
5. Bulera SJ, Theiss JC, Festerling TA, de la Iglesia FA: In vitro phototoxigenic acivity of clinafloxacin: a paradigm predicting photocarcinogenicity Toxicol Appl Pharmacol, 1999, 156, 222-230. (Pubitemid 29222636)
6. Busca R, Berlotto C, Ortonne JP, Ballotti R: Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem, 1996, 271, 31824-31830. (Pubitemid 26422202)
7. Buszman E, Beberok A, Różańska R, Orzechowska A: Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro. Pharmazie, 2008, 63, 372-376. (Pubitemid 351744520)
8. Buszman E, Betlej B, Wrzeoeniok D, Radwańska-Wala B: Effect of metal ions on melanin-local anaesthetic drug complexes. Bioinorg Chem Appl, 2003, 87, 113-122.
9. Buszman E, Różańska R: Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity. Pharmazie, 2003, 58, 507-511. (Pubitemid 36869886)
10. 2+ ions on quinidine, disopyramide and metoprolol interaction with melanin in vitro. Ann Univ Mariae Curie Skłodowska Sectio DDD Pharm, 2009, 4, 75-80.
11. Buszman E, Wrzeoeniok D, Surażynski A, Pałka J, Mole{ogonek}da K: Effect of melanin on netilmicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Bioorg Med Chem, 2006, 14, 8155-8161. (Pubitemid 44667567)
12. Buszman E, Wrzeoeniok D, Trzcionka J: Interaction of neomycin, tobramycin and amikacin with melanin in vi-tro in relation to aminoglycosides-induced ototoxicity. Pharmazie, 2007, 62, 210-215. (Pubitemid 46447202)
13. Chang TS: An updated review of tyrosinase inhibitors. Int J Mol Sci, 2009, 10, 2440-2475.
14. Chung SW, Ha YM, Kim YJ, Song S, Lee H, Suh H: Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis. Arch Pharm Res, 2009, 32, 289-294.
15. Dessinotti C, Stratigos AJ, Rigopulos D, Katsambas AD: A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Exp Dermatol, 2009, 18, 741-749.
16. Fukuda M, Morita Y, Sasaki K, Yamamoto Y: Studied on the binding mechanism of fluoroquinolones to melanin. J Infect Chemother, 2000, 6, 72-76. (Pubitemid 30480298)
17. Gora{ogonek}ca A, Huk-Kolega H, Kleniewska P, Piechota-Kolańczyk A, Skibska B: Effects of lipoic acid on spleen oxidative stress after LPS administration. Pharmacol Rep, 2013, 65, 179-186.
18. Hamanaka M, Mizutani H, Asahig K, Shimizu MJ: Melanocyte melanin augments sparfloxacin-induced phototoxicity. Dermatol Sci, 1999, 21, 27-33. (Pubitemid 29347108)
19. Hu DN, Savage HE, Roberts JE: Uveal melanocytes, ocular pigment epithelium, and Müller cells in culture: in vitro toxicology. Int J Toxicol, 2002, 21, 465-472. (Pubitemid 36090836)
20. Jawaid S, Khan TH, Osborn HM, Williams NA: Tyrosinase activated melanoma prodrugs. Anticancer Agents Med Chem, 2009, 9, 717-727.
21. Jiang S, Liu XM, Dai X, Zhou Q, Lei TC, Beermann F: Regulation of DHICA-mediated antioxidation by dopachrome tautomerase: implication for skin photoprotection against UVA radiation. Free Radic Biol Med, 2010, 48, 1144-1151.
22. Kim DS, Kim SY, Park SH, Choi YG, Kwon SB, Kim MK: Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol Pharm Bull, 2005, 12, 2216-2219.
23. Knörle R, Schniz E, Feuerstein TJ: Drug accumulation in melanin: an affinity chromatographic study. J Chromatogr B, 1998, 714, 171-179. (Pubitemid 28386839)
24. Larsson BS: Interaction between chemicals and melanin. Pigment Cell Res, 1993, 6, 127-133.
25. Li J, Tripathi RC, Tripathi BJ: Drug-induced ocular disorders. Drug Safety, 2008, 31, 127-141. (Pubitemid 351158524)
26. Marrot L, Belaidi JP, Jones C, Perez P, Riou L, Sarasin A, Meunier JR: Molecular responses to photogenotoxic stress induced by the antibiotic lomefloxacin in human skin cells: from DNA damage to apoptosis. J Invest Dermatol, 2003, 121, 596-606. (Pubitemid 37072274)
27. Neumann NJ, Blotz A, Wasinska-Kempka G, Rosenbruch M, Lehmann P, Ahr HJ: Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods. J Photochem Photobiol B Biol, 2005, 79, 25-34. (Pubitemid 40425343)
28. Oliphant CM, Green GM: Quinolones: a comprehensive review. Clin Pharmacol, 2002, 65, 455-464. (Pubitemid 34174022)
29. Ono C, Tanaka MJ: Binding characteristics of fluoroquinolones to synthetic levodopa melanin. J Pharm Pharmacol, 2003, 55, 1127-1133. (Pubitemid 36998654)
30. Owens RC, Ambrose PG: Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis, 2005, 41, 144-147.
31. Ozeki H, Ito S, Wakamatsu K, Thody AJ: Spectrophotometric characterization of eumelanin and pheomelanin in hair. Pigment Cell Res, 1996, 9, 265-270. (Pubitemid 126471124)
32. Persad S, Menon JA, Basu PK, Haberman HF: Binding of imipramine, 8-methoxypsolaren and epinephrine to human blue and brown eyes melanins. J Toxicol Cut Ocul Toxicol, 1986, 5, 125-132. (Pubitemid 16094635)
33. Pitkanen L, Ranta V, Moilanen H, Urtti A: Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium. Pharm Res, 2007, 24, 2063-2070. (Pubitemid 47493576)
34. Potts AM: The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol, 1962, 1, 522-530.
35. Pouzaud F, Dutot M, Martin C, Debray M, Warnet JM, Rat P: Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells. Comp Biochem Physiol C Toxicol Pharmacol, 2006, 143, 232-241.
36. Rampal S, Kaur R, Sethi R, Singh O, Sood N: Ofloxacin-associated retinopathy in rabbits: role of oxidative stress. Hum Exp Toxicol, 2008, 27, 409-415.
37. Ray RS, Agrawal N, Misra RB, Farooq M, Hans RK: Radiation-induced in vitro phototoxic potential of some fluoroqionolones. Drug Chem Toxicol, 2006, 29, 25-38. (Pubitemid 43286712)
38. Różanowska M, Sarna T, Land EJ, Truscott TG: Free radical scavenging properties of melanin interaction of eu-and pheo-melanin models with reducing and oxidising radicals. Free Radic Biol Med, 1999, 26, 518-525. (Pubitemid 29146254)
39. Schallreuter KU, Kothari S, Chavan B, Spencer JD: Regulation of melanogenesis-controversies and new concepts. Exp Dermatol, 2008, 17, 395-404. (Pubitemid 351513953)
40. Smith A, Pennefather PM, Kaye SB, Hart CA: Fluoroquinolones. Place in ocular therapy. Drugs, 2001, 61, 747-761.
41. Surazyński A, Pałka J, Wrzeoeniok D, Buszman E, Kaczmarczyk P: Melanin potentiates daunorubicininduced inhibition of collagen biosynthesis in human skin fibroblasts. Eur J Pharmacol, 2001, 419, 139-145. (Pubitemid 32568212)
42. Thompson AM: Ocular toxicity of fluoroquinolones. Clin Experiment Ophthalmol, 2007, 35, 566-577. (Pubitemid 47337975)
43. Tolleson WH: Human melanocyte biology, toxicology, and pathology. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2005, 23, 105-161. (Pubitemid 41565452)
44. Wrzeoeniok D, Buszman E, Karna E, Nawrat P, Pałka J: Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur J Pharmacol, 2002, 446, 7-13. (Pubitemid 34722552)
45. Yamaguchi Y, Hearing V: Physiological factors that regulate skin pigmentation. Biofactors, 2009, 35, 193-199.
46. Zhao B, Chignell CF, Rammal M, Smith F, Hamilton MG, Andley UP, Roberts JE: Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics Photochem Photobiol, 2010, 86, 798-805.